An update on the pharmacological management of endometriosis

Bibliography

• Bulun SE. Endometriosis. N Engl J Med 2009;360:268-79
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010;376:730-8
   PubMed Web of Science ®Google Scholar
• Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 2005;11:595-606
   PubMed Web of Science ®Google Scholar
• Sampson JA. Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. Am J Pathol 1927;3:93-110; 43
   PubMedGoogle Scholar
• Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235-58
   PubMed Web of Science ®Google Scholar
• Chapron C, Pietin-Vialle C, Borghese B, Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis. Fertil Steril 2009;92:453-7
   PubMed Web of Science ®Google Scholar
• Chapron C, Bourret A, Chopin N, Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions. Hum Reprod 2010;25:884-9
   PubMed Web of Science ®Google Scholar
• Koninckx PR, Meuleman C, Demeyere S, Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991;55:759-65
   PubMed Web of Science ®Google Scholar
• Ichida M, Gomi A, Hiranouchi N, A case of cerebral endometriosis causing catamenial epilepsy. Neurology 1993;43:2708-9
   PubMed Web of Science ®Google Scholar
• Augoulea A, Lambrinoudaki I, Christodoulakos G. Thoracic endometriosis syndrome. Respiration 2008;75:113-19
   PubMed Web of Science ®Google Scholar
• May KE, Villar J, Kirtley S, Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update 2011;17:637-53
   PubMed Web of Science ®Google Scholar
• Abrao MS, Podgaec S, Dias JA Jr, Deeply infiltrating endometriosis affecting the rectum and lymph nodes. Fertil Steril 2006;86:543-7
   PubMed Web of Science ®Google Scholar
• Noel JC, Chapron C, Fayt I, Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril 2008;89:1069-72
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Zanconato G, Is rectovaginal endometriosis a progressive disease? Am J Obstet Gynecol 2004;191:1539-42
   PubMedGoogle Scholar
• Brosens IA. Endometriosis–a disease because it is characterized by bleeding. Am J Obstet Gynecol 1997;176:263-7
   PubMed Web of Science ®Google Scholar
• Vercellini P. Endometriosis: what a pain it is. Semin Reprod Endocrinol 1997;15:251-61
   PubMedGoogle Scholar
• Anaf V, Simon P, El Nakadi I, Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 2000;15:1744-50
   PubMed Web of Science ®Google Scholar
• Kinkel K, Frei KA, Balleyguier C, Diagnosis of endometriosis with imaging: a review. Eur Radiol 2006;16:285-98
   PubMedGoogle Scholar
• Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009;24:496-501
   PubMed Web of Science ®Google Scholar
• Abrao MS, Goncalves MO, Dias JA Jr, Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 2007;22:3092-7
   PubMed Web of Science ®Google Scholar
• Saccardi C, Cosmi E, Borghero A, Ultrasound Obstet Gynecol 2012;40(4):464-9
   Google Scholar
• Piketty M, Chopin N, Dousset B, Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination. Hum Reprod 2009;24:602-7
   PubMed Web of Science ®Google Scholar
• Vercellini P, Pietropaolo G, De Giorgi O, Reproductive performance in infertile women with rectovaginal endometriosis: is surgery worthwhile? Am J Obstet Gynecol 2006;195:1303-10
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani PG, Abbiati A, The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update 2009;15:177-88
   PubMed Web of Science ®Google Scholar
• Dousset B, Leconte M, Borghese B, Complete surgery for low rectal endometriosis: long-term results of a 100-case prospective study. Ann Surg 2010;251:887-95
   PubMed Web of Science ®Google Scholar
• Cheong Y, Tay P, Luk F, Laparoscopic surgery for endometriosis: how often do we need to re-operate? J Obstet Gynaecol 2008;28:82-5
   PubMedGoogle Scholar
• Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol 2004;16:299-303
   PubMed Web of Science ®Google Scholar
• Somigliana E, Chiodini A, Odorizzi MP, The therapy of endometriosis. New prospects. Minerva Ginecol 2003;55:15-23
   PubMedGoogle Scholar
• Weir E, Mustard C, Cohen M, Endometriosis: what is the risk of hospital admission, readmission, and major surgical intervention? J Minim Invasive Gynecol 2005;12:486-93
   PubMed Web of Science ®Google Scholar
• Chapron C, Santulli P, de Ziegler D, Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis. Hum Reprod 2012;27:702-11
   PubMed Web of Science ®Google Scholar
• Hachisuga T, Kawarabayashi T. Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod 2002;17:432-5
   PubMed Web of Science ®Google Scholar
• Hirokawa W, Iwase A, Goto M, The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 2011;26:904-10
   PubMed Web of Science ®Google Scholar
• Somigliana E, Ragni G, Benedetti F, Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod 2003;18:2450-3
   PubMed Web of Science ®Google Scholar
• Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012;97:3146-54
   PubMed Web of Science ®Google Scholar
• Streuli I, de Ziegler D, Gayet V, In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod 2012;27:3294-303
   PubMed Web of Science ®Google Scholar
• Fedele L, Parazzini F, Radici E, Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial. Am J Obstet Gynecol 1992;166:1345-50
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Arcaini L, Buserelin versus danazol in the treatment of endometriosis-associated infertility. Am J Obstet Gynecol 1989;161:871-6
   PubMed Web of Science ®Google Scholar
• Fraser IS, Shearman RP, Jansen RP, A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Aust NZ J Obstet Gynaecol 1991;31:158-63
   PubMed Web of Science ®Google Scholar
• Henzl MR, Corson SL, Moghissi K, Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988;318:485-9
   PubMed Web of Science ®Google Scholar
• Rotondi M, Labriola D, Ammaturo FP, Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. Eur J Gynaecol Oncol 2002;23:523-6
   PubMed Web of Science ®Google Scholar
• Sallam HN, Garcia-Velasco JA, Dias S, Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006;CD004635
   Google Scholar
• de Ziegler D, Gayet V, Aubriot FX, Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril 2010;94:2796-9
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Vigano P, Surgery for endometriosis-associated infertility: a pragmatic approach. Hum Reprod 2009;24:254-69
   PubMed Web of Science ®Google Scholar
• Marjoribanks J, Proctor M, Farquhar C, Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2010;CD001751
   Google Scholar
• Wong CL, Farquhar C, Roberts H, Oral contraceptive pill as treatment for primary dysmenorrhoea. Cochrane Database Syst Rev 2009;CD002120
   Google Scholar
• Chapron C, Borghese B, Streuli I, Markers of adult endometriosis detectable in adolescence. J Pediatr Adolesc Gynecol 2011;24:S7-12
   PubMed Web of Science ®Google Scholar
• Chapron C, Souza C, Borghese B, Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011;26:2028-35
   PubMed Web of Science ®Google Scholar
• Sagsveen M, Farmer JE, Prentice A, Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 2003;CD001297
   Google Scholar
• Surrey ES. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? Curr Opin Obstet Gynecol 2010;22:283-8
   PubMed Web of Science ®Google Scholar
• Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2010;CD008475
   PubMed Web of Science ®Google Scholar
• Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2012;3:CD002122
   PubMed Web of Science ®Google Scholar
• Overton CE, Lindsay PC, Johal B, A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 1994;62:701-7
   PubMed Web of Science ®Google Scholar
• Telimaa S, Puolakka J, Ronnberg L, Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987;1:13-23
   PubMedGoogle Scholar
• McCormack PL. Dienogest: a review of its use in the treatment of endometriosis. Drugs 2010;70:2073-88
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Remmers A, Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women. J Clin Pharmacol 2011
   Google Scholar
• Strowitzki T, Faustmann T, Gerlinger C, Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010;151:193-8
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Marr J, Gerlinger C, Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010;25:633-41
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Marr J, Gerlinger C, Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet 2012;117:228-33
   PubMed Web of Science ®Google Scholar
• Vercellini P, Pietropaolo G, De Giorgi O, Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril 2005;84:1375-87
   PubMed Web of Science ®Google Scholar
• Vercellini P, De Giorgi O, Mosconi P, Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002;77:52-61
   PubMed Web of Science ®Google Scholar
• Fedele L, Arcaini L, Bianchi S, Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis. Obstet Gynecol 1989;73:1000-4
   Google Scholar
• ClinicalTrials registry and results database (US National Institutes database). Available from: www.ClinicalTrials.gov
   Google Scholar
• Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 1990;22:85-90
   PubMed Web of Science ®Google Scholar
• Hidalgo M, Bahamondes L, Perrotti M, Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002;65:129-32
   PubMed Web of Science ®Google Scholar
• Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol 2012;119:519-26
   PubMed Web of Science ®Google Scholar
• Bayoglu Tekin Y, Dilbaz B, Altinbas SK, Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril 2011;95:492-6
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS, Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20:1993-8
   PubMed Web of Science ®Google Scholar
• Wong AY, Tang LC, Chin RK. Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial. Aust NZ J Obstet Gynaecol 2010;50:273-9
   PubMed Web of Science ®Google Scholar
• Lockhat FB, Emembolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Hum Reprod 2004;19:179-84
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003;80:305-9
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Zanconato G, Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485-8
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80:560-3
   PubMed Web of Science ®Google Scholar
• Vercellini P, Barbara G, Somigliana E, Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril 2010;93:2150-61
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Taketani Y, Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008;90:1583-8
   PubMed Web of Science ®Google Scholar
• Vercellini P, Trespidi L, Colombo A, A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993;60:75-9
   PubMed Web of Science ®Google Scholar
• Selak V, Farquhar C, Prentice A, Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2007;CD000068
   PubMed Web of Science ®Google Scholar
• Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 2003;CD001751
   Google Scholar
• Kauppila A, Ronnberg L. Naproxen sodium in dysmenorrhea secondary to endometriosis. Obstet Gynecol 1985;65:379-83
   PubMed Web of Science ®Google Scholar
• Allen C, Hopewell S, Prentice A, Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009;CD004753
   Google Scholar
• Struthers RS, Nicholls AJ, Grundy J, Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J Clin Endocrinol Metab 2009;94:545-51
   PubMed Web of Science ®Google Scholar
• GlobaldData Expert analysis of markets and pipeline pharmaceutical products. Available from: www.globaldata.com
   Google Scholar
• Bulun SE, Sharda G, Rink J, Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J Clin Endocrinol Metab 1996;81:1273-7
   PubMed Web of Science ®Google Scholar
• Colette S, Lousse JC, Defrere S, Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod 2009;24:2133-41
   PubMed Web of Science ®Google Scholar
• Soysal S, Soysal ME, Ozer S, The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004;19:160-7
   PubMed Web of Science ®Google Scholar
• Alborzi S, Hamedi B, Omidvar A, A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol Obstet 2011;284:105-10
   PubMed Web of Science ®Google Scholar
• Gopalkrishnan K, Katkam RR, Sachdeva G, Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: morphometric and ultrastructural studies. Biol Reprod 2003;68:1959-67
   PubMed Web of Science ®Google Scholar
• Brenner RM, Slayden OD, Nath A, Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques. Contraception 2010;81:336-42
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Morales AJ, Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996;65:23-8
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Morales AJ, Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486). Am J Obstet Gynecol 1998;178:1151-6
   PubMed Web of Science ®Google Scholar
• Laschke MW, Menger MD. Anti-angiogenic treatment strategies for the therapy of endometriosis. Hum Reprod Update 2012;18:682-702
   PubMed Web of Science ®Google Scholar
• Hill JA, Haimovici F, Anderson DJ. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 1987;139:2250-4
   PubMed Web of Science ®Google Scholar
• Koninckx PR, Craessaerts M, Timmerman D, Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial. Hum Reprod 2008;23(9):2017-23
   Google Scholar
• Marques LJ, Zheng L, Poulakis N, Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 1999;159:508-11
   PubMed Web of Science ®Google Scholar
• Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol 1994;31:151-62
   PubMed Web of Science ®Google Scholar
• Lv D, Song H, Li Y, Pentoxifylline versus medical therapies for subfertile women with endometriosis. Cochrane Database Syst Rev 2009;CD007677
   Google Scholar
• Balasch J, Creus M, Fabregues F, Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Hum Reprod 1997;12:2046-50
   PubMed Web of Science ®Google Scholar
• Alborzi S, Ghotbi S, Parsanezhad ME, Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study. J Minim Invasive Gynecol 2007;14:54-8
   PubMed Web of Science ®Google Scholar
• Creus M, Fabregues F, Carmona F, Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial. Hum Reprod 2008;23:1910-16
   PubMed Web of Science ®Google Scholar
• Kamencic H, Thiel JA. Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. J Minim Invasive Gynecol 2008;15:62-6
   PubMed Web of Science ®Google Scholar
• Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71
   PubMed Web of Science ®Google Scholar
• Bulun SE, Cheng YH, Pavone ME, Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:36-43
   PubMed Web of Science ®Google Scholar
• Boonyaratanakornkit V. Scaffolding proteins mediating membrane-initiated extranuclear actions of estrogen receptor. Steroids 2011;76(9):877-84
   PubMed Web of Science ®Google Scholar
• Lu Q, Pallas DC, Surks HK, Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 2004;101(49):17126-31
   PubMed Web of Science ®Google Scholar
• Ngo C, Chereau C, Nicco C, Reactive oxygen species controls endometriosis progression. Am J Pathol 2009;175:225-34
   PubMed Web of Science ®Google Scholar
• Leconte M, Nicco C, Ngo C, The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. Am J Pathol 2011;179:880-9
   PubMed Web of Science ®Google Scholar
• Leconte M, Nicco C, Ngo C, Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol 2010;177:2963-70
   PubMed Web of Science ®Google Scholar
• Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol 1987;156:783-9
   PubMed Web of Science ®Google Scholar
• Halme J, White C, Kauma S, Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab 1988;66:1044-9
   PubMed Web of Science ®Google Scholar
• Ngo C, Nicco C, Leconte M, Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo. Fertil Steril 2010;94(5):1632-8; e1
   PubMed Web of Science ®Google Scholar
• Ngo C, Nicco C, Leconte M, Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. J Pathol 2010;222:148-57
   PubMed Web of Science ®Google Scholar
• Dooley A, Bruckdorfer KR, Abraham DJ. Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants. Cardiol Res Pract 2012;2012:521958
   PubMedGoogle Scholar
• Yotova IY, Quan P, Leditznig N, Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis. Hum Reprod 2011;26:885-97
   PubMed Web of Science ®Google Scholar
• Santulli P, Marcellin L, Noel JC, Sphingosine pathway deregulation in endometriotic tissues. Fertil Steril 2012;97:904-11
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Chang RJ, Lu J, “Medical oophorectomy” using a long-acting GNRH agonist–a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982;54:1081-3
   PubMed Web of Science ®Google Scholar
• Steingold KA, Cedars M, Lu JK, Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet Gynecol 1987;69:403-11
   PubMed Web of Science ®Google Scholar
• Schriock E, Monroe SE, Henzl M, Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin). Fertil Steril 1985;44:583-8
   PubMed Web of Science ®Google Scholar
• Miller JD, Shaw RW, Casper RF, Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist. Fertil Steril 1998;70:293-6
   PubMed Web of Science ®Google Scholar
• Paoletti AM, Serra GG, Cagnacci A, Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 1996;65:707-10
   PubMed Web of Science ®Google Scholar
• Cedars MI, Lu JK, Meldrum DR, Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstet Gynecol 1990;75:641-5
   PubMed Web of Science ®Google Scholar
• Surrey ES, Gambone JC, Lu JK, The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis. Fertil Steril 1990;53:620-6
   Google Scholar
• Kiilholma P, Tuimala R, Kivinen S, Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril 1995;64:903-8
   PubMed Web of Science ®Google Scholar
• Moghissi KS, Schlaff WD, Olive DL, Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril 1998;69:1056-62
   PubMed Web of Science ®Google Scholar
• Surrey ES, Silverberg KM, Surrey MW, Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002;78:699-704
   PubMed Web of Science ®Google Scholar
• Maia H Jr, Casoy J, Correia T, The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis. Gynecol Endocrinol 2008;24:123-8
   PubMed Web of Science ®Google Scholar
• Tokushige N, Markham R, Russell P, High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod 2006;21:782-7
   PubMed Web of Science ®Google Scholar
• Tokushige N, Markham R, Russell P, Effects of hormonal treatment on nerve fibers in endometrium and myometrium in women with endometriosis. Fertil Steril 2008;90:1589-98
   PubMed Web of Science ®Google Scholar
• Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril 2012
   Google Scholar
• Ferrero S, Venturini PL, Ragni N, Pharmacological treatment of endometriosis: experience with aromatase inhibitors. Drugs 2009;69:943-52
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Carda C, Noguera I, Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod 2009;24:1025-35
   PubMed Web of Science ®Google Scholar